BRPI0922983A2 - comprimidos de desintegração rápida de capecitabina - Google Patents

comprimidos de desintegração rápida de capecitabina

Info

Publication number
BRPI0922983A2
BRPI0922983A2 BRPI0922983A BRPI0922983A BRPI0922983A2 BR PI0922983 A2 BRPI0922983 A2 BR PI0922983A2 BR PI0922983 A BRPI0922983 A BR PI0922983A BR PI0922983 A BRPI0922983 A BR PI0922983A BR PI0922983 A2 BRPI0922983 A2 BR PI0922983A2
Authority
BR
Brazil
Prior art keywords
capecitabine
disintegrating tablets
rapid disintegrating
rapid
tablets
Prior art date
Application number
BRPI0922983A
Other languages
English (en)
Inventor
Maria Oksana Bachynsky
Mohammad Rashed
Navnit Hargovindas Shah
Paul Anthony Samtak
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41600677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0922983(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0922983A2 publication Critical patent/BRPI0922983A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BRPI0922983A 2008-12-16 2009-12-07 comprimidos de desintegração rápida de capecitabina BRPI0922983A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12276608P 2008-12-16 2008-12-16
PCT/EP2009/066490 WO2010069795A2 (en) 2008-12-16 2009-12-07 Capecitabine rapidly disintegrating tablets

Publications (1)

Publication Number Publication Date
BRPI0922983A2 true BRPI0922983A2 (pt) 2016-01-26

Family

ID=41600677

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922983A BRPI0922983A2 (pt) 2008-12-16 2009-12-07 comprimidos de desintegração rápida de capecitabina

Country Status (17)

Country Link
US (1) US20110027374A1 (pt)
EP (1) EP2379065A2 (pt)
JP (1) JP2012512142A (pt)
KR (1) KR20110086857A (pt)
CN (1) CN102369002A (pt)
AR (1) AR074739A1 (pt)
AU (1) AU2009328348A1 (pt)
BR (1) BRPI0922983A2 (pt)
CA (1) CA2745279A1 (pt)
IL (1) IL212735A0 (pt)
MX (1) MX2011006026A (pt)
PE (1) PE20110583A1 (pt)
RU (1) RU2011129205A (pt)
SG (1) SG172191A1 (pt)
TW (1) TW201028156A (pt)
WO (1) WO2010069795A2 (pt)
ZA (1) ZA201103986B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107252419A (zh) 2010-12-22 2017-10-17 巴斯夫欧洲公司 快速崩解的固体包衣剂型
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
CN102266303A (zh) * 2011-07-07 2011-12-07 程雪翔 一种卡培他滨药用组合物及其制备方法
US20140309183A1 (en) * 2011-08-24 2014-10-16 David Kerr Low-Dose Combination Chemotherapy
CN102988320B (zh) * 2012-12-13 2014-04-16 哈药集团技术中心 一种卡培他滨分散片及其制备方法
CN104337783B (zh) * 2013-08-02 2018-06-22 山东新时代药业有限公司 一种卡培他滨片剂及其制备方法
CN104997744B (zh) * 2015-08-04 2018-01-23 青岛市中心医院 一种高稳定性卡培他滨片剂及其制备方法
JP6673798B2 (ja) * 2016-10-12 2020-03-25 日本化薬株式会社 カペシタビンを有効成分とするフィルムコート医薬製剤
JP6866113B2 (ja) * 2016-11-01 2021-04-28 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤
JP6792418B2 (ja) * 2016-11-08 2020-11-25 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤の製造方法
BR112020004035A2 (pt) * 2017-12-08 2020-09-01 F. Hoffmann-La Roche Ag formulação farmacêutica
WO2021033144A1 (en) * 2019-08-20 2021-02-25 Intas Pharmaceuticals Ltd. Oral suspension of capecitabine
KR20230012572A (ko) * 2020-05-19 2023-01-26 셀릭스 바이오 프라이빗 리미티드 암을 치료하기 위한 약학 제형 및 이의 제조
CN115666516A (zh) * 2020-06-01 2023-01-31 希尔帕医疗保健有限公司 包括卡培他滨的快速分散药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
KR20030081472A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
EP1634586B1 (en) * 2004-09-09 2007-02-14 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Fast water-dispersible domperidone tablets
WO2006070845A1 (ja) * 2004-12-28 2006-07-06 Eisai R & D Management Co., Ltd. 速崩壊性錠剤及びその製造方法
GB2442615A (en) * 2005-04-12 2008-04-09 Elan Pharma Int Ltd Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
US8425935B2 (en) * 2005-12-21 2013-04-23 Basf Se Pharmaceutical formulation for producing rapidly disintegrating tablets
US8313777B2 (en) * 2006-10-05 2012-11-20 The Johns Hopkins University Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets

Also Published As

Publication number Publication date
WO2010069795A3 (en) 2010-10-07
RU2011129205A (ru) 2013-01-27
EP2379065A2 (en) 2011-10-26
ZA201103986B (en) 2012-02-29
JP2012512142A (ja) 2012-05-31
PE20110583A1 (es) 2011-08-17
IL212735A0 (en) 2011-07-31
MX2011006026A (es) 2011-06-21
SG172191A1 (en) 2011-07-28
WO2010069795A2 (en) 2010-06-24
US20110027374A1 (en) 2011-02-03
KR20110086857A (ko) 2011-08-01
TW201028156A (en) 2010-08-01
CN102369002A (zh) 2012-03-07
AR074739A1 (es) 2011-02-09
CA2745279A1 (en) 2010-06-24
AU2009328348A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
BRPI0922983A2 (pt) comprimidos de desintegração rápida de capecitabina
PT2231689T (pt) Novos nucleósidos 7-deazapurina citostáticos
EP3270564C0 (en) Distributed security provisioning
DK3090730T3 (da) Tabletter omfattende eltrombopag-olamin
DK2511282T3 (da) Uracylspirooxetannukleosider
EP2281635A4 (en) CUTTER
EP2307845A4 (en) LOCK HOLSTER
BRPI1014085A2 (pt) comprimido revestido de desintegração oral
EP2320875A4 (en) SAFE TRACKING OF TABLETS
EP3988147C0 (en) INSERT SET
EP2251005A4 (en) Orally disintegrating tablets
ITVR20080024A1 (it) Struttura di tramoggia
BRPI0810926A2 (pt) Antagonista de crig
BRPI0813995A2 (pt) Disposição de blindagem
BRPI0812387A2 (pt) Macadores de polinucleotídeo
BRPI0810559A2 (pt) Macadores de doenças
BRPI0915851A2 (pt) grelha de peneiração melhorada
DK2349661T3 (da) Komprimator
BRPI0821735A2 (pt) Fabricação de tablete
EP2507208A4 (en) HARD OVERBASIC MAGNESIUM ALKYL TOLUOL SULPHONATE
DK2272763T3 (da) Blisterpakning-dispensermaskine
EP2126259A4 (en) Lock device
BRPI0807984A2 (pt) Unidade de distribuição
BRPI0921487A2 (pt) triturador cônico
BR112012002537A2 (pt) conjunto de fechadura

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]